FDA import alert status
Homart Pharmaceuticals Pty. Ltd.
Australia · appears on 2 FDA import alerts
2
Red-list alerts
0
Green-list alerts
Australia
Country
07/31/2024
Last entry seen
What this means
As published on the official FDA import alert list, this firm appears on 2 red lists. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-07-21 UTC).
Do you buy from Homart Pharmaceuticals Pty. Ltd.?
Put this supplier on watch: we re-check the official FDA import alert list daily and email you the day Homart Pharmaceuticals Pty. Ltd. is added to a red list — or removed from one — so a detained shipment never catches you by surprise.
Red-list entries
- Import Alert 66-41RED · 07/26/2024
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Import Alert 99-39RED · 07/31/2024
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Is Homart Pharmaceuticals Pty. Ltd. in your supply chain? Watch your suppliers from $19/mo →